1-((4-iodophenyl)sulfonyl)pyrrolidine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-((4-iodophenyl)sulfonyl)pyrrolidine
• 英文别名: (3R)-1-[(4-iodophenyl)sulfonyl]tetrahydro-1H-3-pyrrole；1-(4-iodophenyl)sulfonylpyrrolidine
• 化学式: C₁₀H₁₂INO₂S
• 分子量: 337.181
• InChiKey: UGEWCHMKMWUJKV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-((4-iodophenyl)sulfonyl)pyrrolidine 在 2-吡啶甲酸 、 potassium phosphate 、 copper(l) iodide 、 三溴化硼 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 22.0h， 生成 5-Chloro-2-(4-pyrrolidin-1-ylsulfonylphenoxy)phenol
  参考文献：
  名称：

  Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase

  摘要：

  Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan's poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.02.019
• 作为产物：
  描述：

  1,4-丁二醇 、 1-磺酰胺-4-碘苯 在 三氟甲磺酸酐 作用下， 以 甲苯 为溶剂， 反应 48.0h， 以46%的产率得到1-((4-iodophenyl)sulfonyl)pyrrolidine
  参考文献：
  名称：

  N-Alkylation of Sulfonamides with Alcohols by Tf₂O

  摘要：

  N-磺酰吡咯烷和N-烷基磺酰胺通过Tf2O对磺酰胺与1,4-二醇或醇的烷基化反应高效合成。该反应在温和的反应条件下进行，产率中等到高，并且耐受芳香族和脂肪族磺酰胺。

  DOI：

  10.1246/bcsj.20150005

文献信息

• Iodine-catalyzed sulfonylation of sulfonyl hydrazides with <i>tert</i>-amines: a green and efficient protocol for the synthesis of sulfonamides
  作者：Jinyang Chen、Xiaoran Han、Lan Mei、Jinchuan Liu、Kui Du、Tuanwu Cao、Qiang Li

  DOI：10.1039/c9ra07361b

  日期：——

  This study provides a direct, sustainable and eco-friendly method for the synthesis of various sulfonamides via the sulfonylation of sulfonyl hydrazides with tert-amines. The method utilizes sulfonyl hydrazides to oxidize and couple with tertiary amines through selective cleavage of C–N bonds. In this reaction, molecular iodine was used as the catalyst and t-butyl hydroperoxide was used as the oxidant

  该研究为通过磺酰肼与叔胺磺酰化合成各种磺胺类药物提供了一种直接、可持续和环保的方法。该方法利用磺酰肼氧化并通过选择性裂解 C-N 键与叔胺偶联。在该反应中，分子碘用作催化​​剂，叔丁基过氧化氢用作氧化剂。
• TBAI-catalyzed selective synthesis of sulfonamides and β-aryl sulfonyl enamines: coupling of arenesulfonyl chlorides and sodium sulfinates with <i>tert</i>-amines
  作者：Hongmei Jiang、Xiaoyue Tang、Zhihui Xu、Huixian Wang、Kang Han、Xiaolan Yang、Yuanyuan Zhou、Yong-Lai Feng、Xian-Yong Yu、Qingwen Gui

  DOI：10.1039/c8ob02992j

  日期：——

  A simple, practical and metal-free method has been developed for the synthesis of sulfonamides and β-arylsulfonyl enamines via the selective cleavage of C–N and C–H bonds through the iodine-catalyzed oxidation of arenesulfonyl chlorides and sodium sulfinates with tert-amines. The method uses commercially available inexpensive catalysts and oxidants, and has a wide substrate scope and operational simplicity

  一种简单，实用和不含金属的方法已被开发用于磺酰胺和β-芳基磺酰基的烯胺的合成通过的C-N和C-H键的选择性裂解通过芳烃磺酰基氯化物和钠基亚磺酸盐的碘催化氧化用叔-胺类。该方法使用可商购的廉价催化剂和氧化剂，并且具有广泛的底物范围和操作简便性。
• Differentiation and functionalization of remote C–H bonds in adjacent positions
  作者：Hang Shi、Yi Lu、Jiang Weng、Katherine L. Bay、Xiangyang Chen、Keita Tanaka、Pritha Verma、Kendall N. Houk、Jin-Quan Yu

  DOI：10.1038/s41557-020-0424-5

  日期：2020.4

  two positions. Herein, we report the design of a catalytic system leveraging a remote directing template and a transient norbornene mediator to selectively activate a previously inaccessible remote C-H bond that is one bond further away. The generality of this approach has been demonstrated with a range of heterocycles, including a complex anti-leukaemia agent and hydrocinnamic acid substrates.

  CH键的位点选择性官能化最终将为化学家提供用于编辑和构建复杂分子结构的转化工具。为了实现这一目标，至关重要的是要开发出激活功能团末端CH键的策略。在这种情况下，由于两个位置之间缺乏电子或位阻，因此区分相邻碳原子上的远程CH键是一个巨大的挑战。在本文中，我们报告了催化系统的设计，该催化系统利用远程指导模板和瞬态降冰片烯介体来选择性激活较远的一个键之前无法访问的远程CH键。这种方法的普遍性已通过一系列杂环得到了证明，其中包括复杂的抗白血病药和氢肉桂酸底物。
• New phenylpyridylpiperazine compounds
  申请人：Desos Patrice

  公开号：US20060258670A1

  公开（公告）日：2006-11-16

  A compound selected from those of formula (I): wherein: X represents a C(O) or SO 2 group, R 1 represents an aryl group or a group NR 3 R 4 wherein R 3 and R 4 are as defined in the description, R 2 represents an alkyl, (C 3 -C 8 )cycloalkyl or (C 3 -C 8 )cycloalkyl-(C 1 -C 6 )alkyl group, its isomers, and addition salts thereof, and medicinal products containing the same which are useful in treating conditions treatable by antagonists of type H 3 central histamine receptors.

  从式(I)中选择的一种化合物： 其中： X代表C(O)或SO2基团， R1代表芳基或基团NR3R4，其中R3和R4如描述中所定义， R2代表烷基，(C3-C8)环烷基或(C3-C8)环烷基-(C1-C6)烷基基团，其异构体和其盐， 以及含有这种化合物的药物产品，用于治疗可通过H3型中枢组胺受体拮抗剂治疗的疾病。
• [EN] MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS<br/>[FR] COMPOSÉS DE MORPHOLINONE EN TANT QU'INHIBITEURS DE FACTEUR IXA
  申请人：MOCHIDA PHARM CO LTD

  公开号：WO2010065717A1

  公开（公告）日：2010-06-10

  The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

  本发明提供了如下描述的化合物I的化合物，或其药用可接受的盐或溶剂。本发明还提供包含一个或多个所述化合物的药物组合物，以及使用所述化合物治疗或预防血栓、栓塞、高凝血性或纤维变化的方法。